Iron Deficiency Anemia Epidemiology Forecast 2025-2034

The World Health Organisation (WHO) considers iron deficiency anemia as the most common nutritional deficiency, with approximately 30% of the global population affected by this condition. Iron deficiency anemia is reported to have a high prevalence in children and women. However, adult men are also prone to developing the condition depending on their health condition and socioeconomic status.

Iron Deficiency Anemia Epidemiology Forecast Report Coverage

The “Iron Deficiency Anemia Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of iron deficiency anemia. It projects the future incidence and prevalence rates of iron deficiency anemia across various populations. The study covers age, gender, and type as major determinants of the iron deficiency anemia-affected population. The report highlights patterns in the prevalence of iron deficiency anemia over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of iron deficiency anemia in the 8 major markets.

Regions Covered

• The United States
• United Kingdom
• France
• Italy
• Spain
• Germany
• Japan
• India

Iron Deficiency Anemia Disease Overview

Iron deficiency anemia is a type of anemia characterized by insufficient levels of iron in the body. Since iron is needed to produce red blood cells, this condition can lead to a reduction in the amount of oxygen delivered to the organs and tissues. Fatigue, pale or yellow skin, weakness, headache, and rapid heartbeat are some of the symptoms of iron deficiency anemia. Age, genetic predisposition, lifestyle patterns, gender, and lead exposure include the risk factors for developing iron deficiency anemia.

Iron Deficiency Anemia: Treatment Overview

Iron supplements (orally or intravenously) are typically used to treat iron deficiency anemia. Oral iron supplements usually take 3 to 6 months to restore iron levels. Intravenous iron is used in severe cases and can help restore iron levels in one or a few sessions. Increasing the intake of iron-rich food and treating the underlying cause of anemia (like ulcers or heavy periods) can also aid in increasing the amount of iron in the body. Erythropoiesis stimulating agents (ESA) are also prescribed in certain cases to help bone marrow produce more red blood cells.

Epidemiology

The iron deficiency anemia epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for iron deficiency anemia by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for iron deficiency anemia and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• Iron deficiency anemia affects 30% of the global population, with menstruation and gastrointestinal bleeding the most common causes of the condition in women.
• According to the World Health Organisation (WHO), 40% of all children between the ages of 6 to 59 months, 37% of pregnant women, and 30% of women aged between 15 and 49 years are affected by anemia.
• Iron deficiency is the most prevalent cause of anemia, with around 2 billion people reported to be iron deficient across the globe.
• As per a qualitative study published in Nutrition (2021), about 50% of women of reproductive age have iron deficiency anemia in India compared to 23% of men.

Country-wise Iron Deficiency Anemia Epidemiology

The iron deficiency anemia epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of iron deficiency anemia differs between countries due to several factors including variations in dietary habits, the prevalence of parasitic infections, chronic inflammatory diseases or gastrointestinal disorders, public health initiatives, and socioeconomic status, among others. In the United States, around 18% of pregnant individuals are affected by iron deficiency and approximately 5% of this population have iron deficiency anemia.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of iron deficiency anemia based on several factors.
• Iron Deficiency Anemia Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of iron deficiency anemia are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of iron deficiency anemia epidemiology in the 8 major markets?
• What will be the total number of patients with iron deficiency anemia across the 8 major markets during the forecast period?
• What was the country-wise prevalence of iron deficiency anemia in the 8 major markets in the historical period?
• Which country will have the highest number of iron deficiency anemia patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of iron deficiency anemia during the forecast period of 2025-2034?
• What are the currently available treatments for iron deficiency anemia?
• What are the disease risks, signs, symptoms, and unmet needs of iron deficiency anemia?

This product will be delivered within 3-5 business days.